革新的医薬品の世界市場：市場レポート、競合分析、地域別機会 (2025年～2031年)

当レポートは、革新的医薬品 (Innovative Drug) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

• 調査範囲
• 市場：タイプ別
  • 世界のタイプ別市場成長: 2020 VS 2024 VS 2031
  • Biological Medicine
  • Chemical Medicine
• 市場：用途別
  • 世界の用途別市場シェア: 2020 VS 2024 VS 2031
  • Oncology
  • Neurology and Psychiatry
  • Infectious Diseases
  • Metabolic Diseases
  • Inflammatory Diseases
  • Others
• 前提条件と制限
• 調査目的
• 対象期間

第2章 世界の市場成長トレンド

• 世界の革新的医薬品の市場展望 (2020-2031)
• 世界の市場規模：地域別: 2020 VS 2024 VS 2031
• 世界の革新的医薬品の収益市場シェア 地域別 (2020-2025)
• 世界の革新的医薬品の収益予測：地域別 (2026-2031)
• 主要地域と新興市場分析
  • 北米の革新的医薬品 市場規模および予測 (2020-2031)
  • 欧州の革新的医薬品 市場規模および予測 (2020-2031)
  • 中国の革新的医薬品 市場規模および予測 (2020-2031)
  • 日本の革新的医薬品 市場規模および予測 (2020-2031)
  • 東南アジア 革新的医薬品 市場規模および予測 (2020-2031)
  • インド 革新的医薬品 市場規模および予測 (2020-2031)
  • 中米 革新的医薬品 市場規模および予測 (2020-2031)

第3章 内訳データ：タイプ別

• 世界の革新的医薬品の市場規模実績：タイプ別 (2020-2025)
• 世界の革新的医薬品の市場規模予測：タイプ別 (2026-2031)
• 各種タイプ 革新的医薬品 代表的な企業

第4章 内訳データ：用途別

• 世界の革新的医薬品の市場規模実績：用途別 (2020-2025)
• 世界の革新的医薬品の市場規模予測：用途別 (2026-2031)
• 新たな成長源 革新的医薬品 アプリケーション

第5章 競合他社の状況

• 世界トップ企業 収益
  • 世界の革新的医薬品の上位企業：収益別 (2020-2025)
  • 世界の革新的医薬品の収益シェア：企業別 (2020-2025)
• 世界の企業タイプ別市場シェア (Tier 1, Tier 2, and Tier 3)
• 企業ランキング： 革新的医薬品 収益
• 世界の革新的医薬品 市場集中度分析
  • 世界の革新的医薬品 市場集中度 (CR5 and HHI)
  • 世界の上位10・上位5企業： 革新的医薬品 収益 2024年
• 世界の主要企業 革新的医薬品 本社 および提供地域
• 世界の主要企業 革新的医薬品, 製品およびアプリケーション
• 世界の主要企業 革新的医薬品, 業界参入時期
• M&A, 拡張計画

第6章 地域分析

• 北米の市場: Pレイヤー, セグメントs and 下流
  • 北米の革新的医薬品 企業別収益 (2020-2025)
  • 北米の市場規模：タイプ別
  • 北米の市場規模：用途別
  • 北米の市場 トレンドと機会
• 欧州の市場: Pレイヤー, セグメントs and 下流
  • 欧州の革新的医薬品 企業別収益 (2020-2025)
  • 欧州の市場規模：タイプ別
  • 欧州の市場規模：用途別
  • 欧州の市場 トレンドと機会
• 中国の市場: Pレイヤー, セグメントs and 下流
  • 中国の革新的医薬品 企業別収益 (2020-2025)
  • 中国の市場規模：タイプ別
  • 中国の市場規模：用途別
  • 中国の市場 トレンドと機会
• 日本の市場: Pレイヤー, セグメントs and 下流
  • 日本の革新的医薬品 企業別収益 (2020-2025)
  • 日本の市場規模：タイプ別
  • 日本の市場規模：用途別
  • 日本の市場 トレンドと機会
• 東南アジア 市場: Pレイヤー, セグメントs and 下流
  • 東南アジア 革新的医薬品 企業別収益 (2020-2025)
  • 東南アジア 市場規模：タイプ別
  • 東南アジア 市場規模：用途別
  • 東南アジア 市場 トレンドと機会
• インド 市場: Pレイヤー, セグメントs and 下流
  • インド 革新的医薬品 企業別収益 (2020-2025)
  • インド 市場規模：タイプ別
  • インド 市場規模：用途別
  • インド 市場 トレンドと機会

第7章 主要企業のプロファイル

• Pfizer
• Roche
• Sanofi
• Johnson & Johnson
• Merck & Co. (MSD)
• Novartis
• AbbVie
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Eli Lilly and Company
• Teva Pharmaceutical Industries
• Bayer
• Novo Nordisk
• Takeda Pharmaceutical Company
• Boehringer Ingelheim
• HUTCHMED
• BeiGene
• Legend Biotech
• Shanghai Junshi Biosciences
• Hengrui Pharmaceuticals
• Chia Tai Tianqing Pharmaceutical

第8章 革新的医薬品 市場動向

• 革新的医薬品 業界動向
• 革新的医薬品 市場の促進要因
• 革新的医薬品 市場の課題
• 革新的医薬品 市場の抑制要因

第9章 市場調査結果と結論

第10章 付録

List of Tables

Table 1. Global Innovative Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Innovative Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Innovative Drug Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Innovative Drug Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Innovative Drug Revenue Share by Region (2020-2025)

Table 6. Global Innovative Drug Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Innovative Drug Revenue Share Forecast by Region (2026-2031)

Table 8. Global Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Innovative Drug Revenue Market Share by Type (2020-2025)

Table 10. Global Innovative Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Innovative Drug Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Innovative Drug Revenue Market Share by Application (2020-2025)

Table 15. Global Innovative Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Innovative Drug Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Innovative Drug Application

Table 18. Global Innovative Drug Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Innovative Drug Market Share by Players (2020-2025)

Table 20. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug as of 2024)

Table 21. Ranking of Global Top Innovative Drug Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Innovative Drug Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Innovative Drug, Headquarters and Area Served

Table 24. Global Key Players of Innovative Drug, Product and Application

Table 25. Global Key Players of Innovative Drug, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Innovative Drug Revenue Market Share by Company (2020-2025)

Table 29. North America Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Innovative Drug Revenue Market Share by Company (2020-2025)

Table 33. Europe Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Innovative Drug Revenue Market Share by Company (2020-2025)

Table 37. China Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Innovative Drug Revenue Market Share by Company (2020-2025)

Table 41. Japan Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 43. Southeast Asia Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 44. Southeast Asia Innovative Drug Revenue Market Share by Company (2020-2025)

Table 45. Southeast Asia Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 46. Southeast Asia Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 47. India Innovative Drug Revenue by Company (2020-2025) & (US$ Million)

Table 48. India Innovative Drug Revenue Market Share by Company (2020-2025)

Table 49. India Innovative Drug Market Size by Type (2020-2025) & (US$ Million)

Table 50. India Innovative Drug Market Size by Application (2020-2025) & (US$ Million)

Table 51. Pfizer Company Details

Table 52. Pfizer Business Overview

Table 53. Pfizer Innovative Drug Product

Table 54. Pfizer Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 55. Pfizer Recent Development

Table 56. Roche Company Details

Table 57. Roche Business Overview

Table 58. Roche Innovative Drug Product

Table 59. Roche Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 60. Roche Recent Development

Table 61. Sanofi Company Details

Table 62. Sanofi Business Overview

Table 63. Sanofi Innovative Drug Product

Table 64. Sanofi Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 65. Sanofi Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Innovative Drug Product

Table 69. Johnson & Johnson Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Merck & Co. (MSD) Company Details

Table 72. Merck & Co. (MSD) Business Overview

Table 73. Merck & Co. (MSD) Innovative Drug Product

Table 74. Merck & Co. (MSD) Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 75. Merck & Co. (MSD) Recent Development

Table 76. Novartis Company Details

Table 77. Novartis Business Overview

Table 78. Novartis Innovative Drug Product

Table 79. Novartis Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 80. Novartis Recent Development

Table 81. AbbVie Company Details

Table 82. AbbVie Business Overview

Table 83. AbbVie Innovative Drug Product

Table 84. AbbVie Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 85. AbbVie Recent Development

Table 86. Gilead Sciences Company Details

Table 87. Gilead Sciences Business Overview

Table 88. Gilead Sciences Innovative Drug Product

Table 89. Gilead Sciences Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 90. Gilead Sciences Recent Development

Table 91. GlaxoSmithKline (GSK) Company Details

Table 92. GlaxoSmithKline (GSK) Business Overview

Table 93. GlaxoSmithKline (GSK) Innovative Drug Product

Table 94. GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 95. GlaxoSmithKline (GSK) Recent Development

Table 96. Amgen Company Details

Table 97. Amgen Business Overview

Table 98. Amgen Innovative Drug Product

Table 99. Amgen Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 100. Amgen Recent Development

Table 101. AstraZeneca Company Details

Table 102. AstraZeneca Business Overview

Table 103. AstraZeneca Innovative Drug Product

Table 104. AstraZeneca Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 105. AstraZeneca Recent Development

Table 106. Bristol-Myers Squibb Company Details

Table 107. Bristol-Myers Squibb Business Overview

Table 108. Bristol-Myers Squibb Innovative Drug Product

Table 109. Bristol-Myers Squibb Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 110. Bristol-Myers Squibb Recent Development

Table 111. Eli Lilly and Company Company Details

Table 112. Eli Lilly and Company Business Overview

Table 113. Eli Lilly and Company Innovative Drug Product

Table 114. Eli Lilly and Company Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 115. Eli Lilly and Company Recent Development

Table 116. Teva Pharmaceutical Industries Company Details

Table 117. Teva Pharmaceutical Industries Business Overview

Table 118. Teva Pharmaceutical Industries Innovative Drug Product

Table 119. Teva Pharmaceutical Industries Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 120. Teva Pharmaceutical Industries Recent Development

Table 121. Bayer Company Details

Table 122. Bayer Business Overview

Table 123. Bayer Innovative Drug Product

Table 124. Bayer Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 125. Bayer Recent Development

Table 126. Novo Nordisk Company Details

Table 127. Novo Nordisk Business Overview

Table 128. Novo Nordisk Innovative Drug Product

Table 129. Novo Nordisk Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 130. Novo Nordisk Recent Development

Table 131. Takeda Pharmaceutical Company Company Details

Table 132. Takeda Pharmaceutical Company Business Overview

Table 133. Takeda Pharmaceutical Company Innovative Drug Product

Table 134. Takeda Pharmaceutical Company Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 135. Takeda Pharmaceutical Company Recent Development

Table 136. Boehringer Ingelheim Company Details

Table 137. Boehringer Ingelheim Business Overview

Table 138. Boehringer Ingelheim Innovative Drug Product

Table 139. Boehringer Ingelheim Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 140. Boehringer Ingelheim Recent Development

Table 141. HUTCHMED Company Details

Table 142. HUTCHMED Business Overview

Table 143. HUTCHMED Innovative Drug Product

Table 144. HUTCHMED Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 145. HUTCHMED Recent Development

Table 146. BeiGene Company Details

Table 147. BeiGene Business Overview

Table 148. BeiGene Innovative Drug Product

Table 149. BeiGene Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 150. BeiGene Recent Development

Table 151. Legend Biotech Company Details

Table 152. Legend Biotech Business Overview

Table 153. Legend Biotech Innovative Drug Product

Table 154. Legend Biotech Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 155. Legend Biotech Recent Development

Table 156. Shanghai Junshi Biosciences Company Details

Table 157. Shanghai Junshi Biosciences Business Overview

Table 158. Shanghai Junshi Biosciences Innovative Drug Product

Table 159. Shanghai Junshi Biosciences Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 160. Shanghai Junshi Biosciences Recent Development

Table 161. Hengrui Pharmaceuticals Company Details

Table 162. Hengrui Pharmaceuticals Business Overview

Table 163. Hengrui Pharmaceuticals Innovative Drug Product

Table 164. Hengrui Pharmaceuticals Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 165. Hengrui Pharmaceuticals Recent Development

Table 166. Chia Tai Tianqing Pharmaceutical Company Details

Table 167. Chia Tai Tianqing Pharmaceutical Business Overview

Table 168. Chia Tai Tianqing Pharmaceutical Innovative Drug Product

Table 169. Chia Tai Tianqing Pharmaceutical Revenue in Innovative Drug Business (2020-2025) & (US$ Million)

Table 170. Chia Tai Tianqing Pharmaceutical Recent Development

Table 171. Innovative Drug Market Trends

Table 172. Innovative Drug Market Drivers

Table 173. Innovative Drug Market Challenges

Table 174. Innovative Drug Market Restraints

Table 175. Research Programs/Design for This Report

Table 176. Key Data Information from Secondary Sources

Table 177. Key Data Information from Primary Sources

List of Figures

Figure 1. Innovative Drug Product Picture

Figure 2. Global Innovative Drug Market Share by Type: 2024 VS 2031

Figure 3. Biological Medicine Features

Figure 4. Chemical Medicine Features

Figure 5. Global Innovative Drug Market Share by Application: 2024 VS 2031

Figure 6. Oncology

Figure 7. Neurology and Psychiatry

Figure 8. Infectious Diseases

Figure 9. Metabolic Diseases

Figure 10. Inflammatory Diseases

Figure 11. Others

Figure 12. Innovative Drug Report Years Considered

Figure 13. Global Innovative Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Innovative Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Innovative Drug Revenue Market Share by Region: 2020 VS 2024

Figure 16. North America Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Europe Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. China Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Japan Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. Southeast Asia Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 21. India Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Central & South America Innovative Drug Revenue (US$ Million) Growth Rate (2020-2031)

Figure 23. Global Innovative Drug Market Share by Players in 2024

Figure 24. Global Top Innovative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Innovative Drug as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Innovative Drug Revenue in 2024

Figure 26. North America Innovative Drug Market Share by Type (2020-2025)

Figure 27. North America Innovative Drug Market Share by Application (2020-2025)

Figure 28. Europe Innovative Drug Market Share by Type (2020-2025)

Figure 29. Europe Innovative Drug Market Share by Application (2020-2025)

Figure 30. China Innovative Drug Market Share by Type (2020-2025)

Figure 31. China Innovative Drug Market Share by Application (2020-2025)

Figure 32. Japan Innovative Drug Market Share by Type (2020-2025)

Figure 33. Japan Innovative Drug Market Share by Application (2020-2025)

Figure 34. Southeast Asia Innovative Drug Market Share by Type (2020-2025)

Figure 35. Southeast Asia Innovative Drug Market Share by Application (2020-2025)

Figure 36. India Innovative Drug Market Share by Type (2020-2025)

Figure 37. India Innovative Drug Market Share by Application (2020-2025)

Figure 38. Pfizer Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 39. Roche Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 40. Sanofi Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 41. Johnson & Johnson Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 42. Merck & Co. (MSD) Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 43. Novartis Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 44. AbbVie Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 45. Gilead Sciences Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 46. GlaxoSmithKline (GSK) Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 47. Amgen Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 48. AstraZeneca Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 50. Eli Lilly and Company Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 52. Bayer Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 53. Novo Nordisk Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 54. Takeda Pharmaceutical Company Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 56. HUTCHMED Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 57. BeiGene Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 58. Legend Biotech Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 59. Shanghai Junshi Biosciences Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 60. Hengrui Pharmaceuticals Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 61. Chia Tai Tianqing Pharmaceutical Revenue Growth Rate in Innovative Drug Business (2020-2025)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

This research report focuses on the Innovative Drug Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market by Type
  • 1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
  • 1.2.2 Biological Medicine
  • 1.2.3 Chemical Medicine
• 1.3 Market by Application
  • 1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
  • 1.3.2 Oncology
  • 1.3.3 Neurology and Psychiatry
  • 1.3.4 Infectious Diseases
  • 1.3.5 Metabolic Diseases
  • 1.3.6 Inflammatory Diseases
  • 1.3.7 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Innovative Drug Market Perspective (2020-2031)
• 2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
• 2.3 Global Innovative Drug Revenue Market Share by Region (2020-2025)
• 2.4 Global Innovative Drug Revenue Forecast by Region (2026-2031)
• 2.5 Major Region and Emerging Market Analysis
  • 2.5.1 North America Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.2 Europe Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.3 China Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.4 Japan Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.5 Southeast Asia Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.6 India Innovative Drug Market Size and Prospective (2020-2031)
  • 2.5.7 Central & South America Innovative Drug Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

• 3.1 Global Innovative Drug Historic Market Size by Type (2020-2025)
• 3.2 Global Innovative Drug Forecasted Market Size by Type (2026-2031)
• 3.3 Different Types Innovative Drug Representative Players

4 Breakdown Data by Application

• 4.1 Global Innovative Drug Historic Market Size by Application (2020-2025)
• 4.2 Global Innovative Drug Forecasted Market Size by Application (2026-2031)
• 4.3 New Sources of Growth in Innovative Drug Application

5 Competition Landscape by Players

• 5.1 Global Top Players by Revenue
  • 5.1.1 Global Top Innovative Drug Players by Revenue (2020-2025)
  • 5.1.2 Global Innovative Drug Revenue Market Share by Players (2020-2025)
• 5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 5.3 Players Covered: Ranking by Innovative Drug Revenue
• 5.4 Global Innovative Drug Market Concentration Analysis
  • 5.4.1 Global Innovative Drug Market Concentration Ratio (CR5 and HHI)
  • 5.4.2 Global Top 10 and Top 5 Companies by Innovative Drug Revenue in 2024
• 5.5 Global Key Players of Innovative Drug Head office and Area Served
• 5.6 Global Key Players of Innovative Drug, Product and Application
• 5.7 Global Key Players of Innovative Drug, Date of Enter into This Industry
• 5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

• 6.1 North America Market: Players, Segments and Downstream
  • 6.1.1 North America Innovative Drug Revenue by Company (2020-2025)
  • 6.1.2 North America Market Size by Type
    • 6.1.2.1 North America Innovative Drug Market Size by Type (2020-2025)
    • 6.1.2.2 North America Innovative Drug Market Share by Type (2020-2025)
  • 6.1.3 North America Market Size by Application
    • 6.1.3.1 North America Innovative Drug Market Size by Application (2020-2025)
    • 6.1.3.2 North America Innovative Drug Market Share by Application (2020-2025)
  • 6.1.4 North America Market Trend and Opportunities
• 6.2 Europe Market: Players, Segments and Downstream
  • 6.2.1 Europe Innovative Drug Revenue by Company (2020-2025)
  • 6.2.2 Europe Market Size by Type
    • 6.2.2.1 Europe Innovative Drug Market Size by Type (2020-2025)
    • 6.2.2.2 Europe Innovative Drug Market Share by Type (2020-2025)
  • 6.2.3 Europe Market Size by Application
    • 6.2.3.1 Europe Innovative Drug Market Size by Application (2020-2025)
    • 6.2.3.2 Europe Innovative Drug Market Share by Application (2020-2025)
  • 6.2.4 Europe Market Trend and Opportunities
• 6.3 China Market: Players, Segments and Downstream
  • 6.3.1 China Innovative Drug Revenue by Company (2020-2025)
  • 6.3.2 China Market Size by Type
    • 6.3.2.1 China Innovative Drug Market Size by Type (2020-2025)
    • 6.3.2.2 China Innovative Drug Market Share by Type (2020-2025)
  • 6.3.3 China Market Size by Application
    • 6.3.3.1 China Innovative Drug Market Size by Application (2020-2025)
    • 6.3.3.2 China Innovative Drug Market Share by Application (2020-2025)
  • 6.3.4 China Market Trend and Opportunities
• 6.4 Japan Market: Players, Segments and Downstream
  • 6.4.1 Japan Innovative Drug Revenue by Company (2020-2025)
  • 6.4.2 Japan Market Size by Type
    • 6.4.2.1 Japan Innovative Drug Market Size by Type (2020-2025)
    • 6.4.2.2 Japan Innovative Drug Market Share by Type (2020-2025)
  • 6.4.3 Japan Market Size by Application
    • 6.4.3.1 Japan Innovative Drug Market Size by Application (2020-2025)
    • 6.4.3.2 Japan Innovative Drug Market Share by Application (2020-2025)
  • 6.4.4 Japan Market Trend and Opportunities
• 6.5 Southeast Asia Market: Players, Segments and Downstream
  • 6.5.1 Southeast Asia Innovative Drug Revenue by Company (2020-2025)
  • 6.5.2 Southeast Asia Market Size by Type
    • 6.5.2.1 Southeast Asia Innovative Drug Market Size by Type (2020-2025)
    • 6.5.2.2 Southeast Asia Innovative Drug Market Share by Type (2020-2025)
  • 6.5.3 Southeast Asia Market Size by Application
    • 6.5.3.1 Southeast Asia Innovative Drug Market Size by Application (2020-2025)
    • 6.5.3.2 Southeast Asia Innovative Drug Market Share by Application (2020-2025)
  • 6.5.4 Southeast Asia Market Trend and Opportunities
• 6.6 India Market: Players, Segments and Downstream
  • 6.6.1 India Innovative Drug Revenue by Company (2020-2025)
  • 6.6.2 India Market Size by Type
    • 6.6.2.1 India Innovative Drug Market Size by Type (2020-2025)
    • 6.6.2.2 India Innovative Drug Market Share by Type (2020-2025)
  • 6.6.3 India Market Size by Application
    • 6.6.3.1 India Innovative Drug Market Size by Application (2020-2025)
    • 6.6.3.2 India Innovative Drug Market Share by Application (2020-2025)
  • 6.6.4 India Market Trend and Opportunities

7 Key Players Profiles

• 7.1 Pfizer
  • 7.1.1 Pfizer Company Details
  • 7.1.2 Pfizer Business Overview
  • 7.1.3 Pfizer Innovative Drug Introduction
  • 7.1.4 Pfizer Revenue in Innovative Drug Business (2020-2025)
  • 7.1.5 Pfizer Recent Development
• 7.2 Roche
  • 7.2.1 Roche Company Details
  • 7.2.2 Roche Business Overview
  • 7.2.3 Roche Innovative Drug Introduction
  • 7.2.4 Roche Revenue in Innovative Drug Business (2020-2025)
  • 7.2.5 Roche Recent Development
• 7.3 Sanofi
  • 7.3.1 Sanofi Company Details
  • 7.3.2 Sanofi Business Overview
  • 7.3.3 Sanofi Innovative Drug Introduction
  • 7.3.4 Sanofi Revenue in Innovative Drug Business (2020-2025)
  • 7.3.5 Sanofi Recent Development
• 7.4 Johnson & Johnson
  • 7.4.1 Johnson & Johnson Company Details
  • 7.4.2 Johnson & Johnson Business Overview
  • 7.4.3 Johnson & Johnson Innovative Drug Introduction
  • 7.4.4 Johnson & Johnson Revenue in Innovative Drug Business (2020-2025)
  • 7.4.5 Johnson & Johnson Recent Development
• 7.5 Merck & Co. (MSD)
  • 7.5.1 Merck & Co. (MSD) Company Details
  • 7.5.2 Merck & Co. (MSD) Business Overview
  • 7.5.3 Merck & Co. (MSD) Innovative Drug Introduction
  • 7.5.4 Merck & Co. (MSD) Revenue in Innovative Drug Business (2020-2025)
  • 7.5.5 Merck & Co. (MSD) Recent Development
• 7.6 Novartis
  • 7.6.1 Novartis Company Details
  • 7.6.2 Novartis Business Overview
  • 7.6.3 Novartis Innovative Drug Introduction
  • 7.6.4 Novartis Revenue in Innovative Drug Business (2020-2025)
  • 7.6.5 Novartis Recent Development
• 7.7 AbbVie
  • 7.7.1 AbbVie Company Details
  • 7.7.2 AbbVie Business Overview
  • 7.7.3 AbbVie Innovative Drug Introduction
  • 7.7.4 AbbVie Revenue in Innovative Drug Business (2020-2025)
  • 7.7.5 AbbVie Recent Development
• 7.8 Gilead Sciences
  • 7.8.1 Gilead Sciences Company Details
  • 7.8.2 Gilead Sciences Business Overview
  • 7.8.3 Gilead Sciences Innovative Drug Introduction
  • 7.8.4 Gilead Sciences Revenue in Innovative Drug Business (2020-2025)
  • 7.8.5 Gilead Sciences Recent Development
• 7.9 GlaxoSmithKline (GSK)
  • 7.9.1 GlaxoSmithKline (GSK) Company Details
  • 7.9.2 GlaxoSmithKline (GSK) Business Overview
  • 7.9.3 GlaxoSmithKline (GSK) Innovative Drug Introduction
  • 7.9.4 GlaxoSmithKline (GSK) Revenue in Innovative Drug Business (2020-2025)
  • 7.9.5 GlaxoSmithKline (GSK) Recent Development
• 7.10 Amgen
  • 7.10.1 Amgen Company Details
  • 7.10.2 Amgen Business Overview
  • 7.10.3 Amgen Innovative Drug Introduction
  • 7.10.4 Amgen Revenue in Innovative Drug Business (2020-2025)
  • 7.10.5 Amgen Recent Development
• 7.11 AstraZeneca
  • 7.11.1 AstraZeneca Company Details
  • 7.11.2 AstraZeneca Business Overview
  • 7.11.3 AstraZeneca Innovative Drug Introduction
  • 7.11.4 AstraZeneca Revenue in Innovative Drug Business (2020-2025)
  • 7.11.5 AstraZeneca Recent Development
• 7.12 Bristol-Myers Squibb
  • 7.12.1 Bristol-Myers Squibb Company Details
  • 7.12.2 Bristol-Myers Squibb Business Overview
  • 7.12.3 Bristol-Myers Squibb Innovative Drug Introduction
  • 7.12.4 Bristol-Myers Squibb Revenue in Innovative Drug Business (2020-2025)
  • 7.12.5 Bristol-Myers Squibb Recent Development
• 7.13 Eli Lilly and Company
  • 7.13.1 Eli Lilly and Company Company Details
  • 7.13.2 Eli Lilly and Company Business Overview
  • 7.13.3 Eli Lilly and Company Innovative Drug Introduction
  • 7.13.4 Eli Lilly and Company Revenue in Innovative Drug Business (2020-2025)
  • 7.13.5 Eli Lilly and Company Recent Development
• 7.14 Teva Pharmaceutical Industries
  • 7.14.1 Teva Pharmaceutical Industries Company Details
  • 7.14.2 Teva Pharmaceutical Industries Business Overview
  • 7.14.3 Teva Pharmaceutical Industries Innovative Drug Introduction
  • 7.14.4 Teva Pharmaceutical Industries Revenue in Innovative Drug Business (2020-2025)
  • 7.14.5 Teva Pharmaceutical Industries Recent Development
• 7.15 Bayer
  • 7.15.1 Bayer Company Details
  • 7.15.2 Bayer Business Overview
  • 7.15.3 Bayer Innovative Drug Introduction
  • 7.15.4 Bayer Revenue in Innovative Drug Business (2020-2025)
  • 7.15.5 Bayer Recent Development
• 7.16 Novo Nordisk
  • 7.16.1 Novo Nordisk Company Details
  • 7.16.2 Novo Nordisk Business Overview
  • 7.16.3 Novo Nordisk Innovative Drug Introduction
  • 7.16.4 Novo Nordisk Revenue in Innovative Drug Business (2020-2025)
  • 7.16.5 Novo Nordisk Recent Development
• 7.17 Takeda Pharmaceutical Company
  • 7.17.1 Takeda Pharmaceutical Company Company Details
  • 7.17.2 Takeda Pharmaceutical Company Business Overview
  • 7.17.3 Takeda Pharmaceutical Company Innovative Drug Introduction
  • 7.17.4 Takeda Pharmaceutical Company Revenue in Innovative Drug Business (2020-2025)
  • 7.17.5 Takeda Pharmaceutical Company Recent Development
• 7.18 Boehringer Ingelheim
  • 7.18.1 Boehringer Ingelheim Company Details
  • 7.18.2 Boehringer Ingelheim Business Overview
  • 7.18.3 Boehringer Ingelheim Innovative Drug Introduction
  • 7.18.4 Boehringer Ingelheim Revenue in Innovative Drug Business (2020-2025)
  • 7.18.5 Boehringer Ingelheim Recent Development
• 7.19 HUTCHMED
  • 7.19.1 HUTCHMED Company Details
  • 7.19.2 HUTCHMED Business Overview
  • 7.19.3 HUTCHMED Innovative Drug Introduction
  • 7.19.4 HUTCHMED Revenue in Innovative Drug Business (2020-2025)
  • 7.19.5 HUTCHMED Recent Development
• 7.20 BeiGene
  • 7.20.1 BeiGene Company Details
  • 7.20.2 BeiGene Business Overview
  • 7.20.3 BeiGene Innovative Drug Introduction
  • 7.20.4 BeiGene Revenue in Innovative Drug Business (2020-2025)
  • 7.20.5 BeiGene Recent Development
• 7.21 Legend Biotech
  • 7.21.1 Legend Biotech Company Details
  • 7.21.2 Legend Biotech Business Overview
  • 7.21.3 Legend Biotech Innovative Drug Introduction
  • 7.21.4 Legend Biotech Revenue in Innovative Drug Business (2020-2025)
  • 7.21.5 Legend Biotech Recent Development
• 7.22 Shanghai Junshi Biosciences
  • 7.22.1 Shanghai Junshi Biosciences Company Details
  • 7.22.2 Shanghai Junshi Biosciences Business Overview
  • 7.22.3 Shanghai Junshi Biosciences Innovative Drug Introduction
  • 7.22.4 Shanghai Junshi Biosciences Revenue in Innovative Drug Business (2020-2025)
  • 7.22.5 Shanghai Junshi Biosciences Recent Development
• 7.23 Hengrui Pharmaceuticals
  • 7.23.1 Hengrui Pharmaceuticals Company Details
  • 7.23.2 Hengrui Pharmaceuticals Business Overview
  • 7.23.3 Hengrui Pharmaceuticals Innovative Drug Introduction
  • 7.23.4 Hengrui Pharmaceuticals Revenue in Innovative Drug Business (2020-2025)
  • 7.23.5 Hengrui Pharmaceuticals Recent Development
• 7.24 Chia Tai Tianqing Pharmaceutical
  • 7.24.1 Chia Tai Tianqing Pharmaceutical Company Details
  • 7.24.2 Chia Tai Tianqing Pharmaceutical Business Overview
  • 7.24.3 Chia Tai Tianqing Pharmaceutical Innovative Drug Introduction
  • 7.24.4 Chia Tai Tianqing Pharmaceutical Revenue in Innovative Drug Business (2020-2025)
  • 7.24.5 Chia Tai Tianqing Pharmaceutical Recent Development

8 Innovative Drug Market Dynamics

• 8.1 Innovative Drug Industry Trends
• 8.2 Innovative Drug Market Drivers
• 8.3 Innovative Drug Market Challenges
• 8.4 Innovative Drug Market Restraints

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer